SCHEMBL6207008

SCHEMBL6207008

CSCCC(NC(=O)OC(C)(C)C)C(=O)NC1CCCCC1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 4/20 0.68
HDAC1 Q13547 4/20 0.68
HDAC6 Q9UBN7 1/20 0.68
CTSS P25774 2/20 0.58
CTSK P43235 2/20 0.58
L3MBTL1 Q9Y468 2/20 0.54
LMNA P02545 1/20 0.53
KLK5 Q9Y337 1/20 0.48
EPHX1 P07099 1/20 0.48
TSHR P16473 2/20 0.48
CA2 P00918 1/20 0.46
GAA P10253 1/20 0.46
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
KLK7 P49862 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5218978 1.00 HDAC4 (0.68) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL31291788 0.96 HDAC4 (0.63) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL785870 0.88 CTSS (0.56) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL789305 0.85 CTSS (0.56) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL11249810 0.84 LMNA (0.58) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL28740619 0.84 LMNA (0.58) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL7260228 0.84 LMNA (0.58) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL9718207 0.83 HDAC4 (0.68) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL18460227 0.83 HDAC4 (0.68) HDAC4HDAC1HDAC6CTSSCTSK
SCHEMBL9075549 0.83 HDAC4 (0.49) HDAC4HDAC1HDAC6CTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-A1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2005-08-31 EP disclosed
WO-2004050619-A1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2004-06-17 WO disclosed